In vivo transgenic mutation assays
- 6 June 2000
- journal article
- research article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 35 (3) , 253-259
- https://doi.org/10.1002/(sici)1098-2280(2000)35:3<253::aid-em11>3.0.co;2-j
Abstract
Transgenic rodent gene mutation models provide quick and statistically reliable assays for mutations in the DNA from any tissue. For regulatory applications, assays should be based on neutral genes, be generally available in several laboratories, and be readily transferable. Five or fewer repeated treatments are inadequate to conclude that a compound is negative but more than 90 daily treatments may risk complications. A sampling time of 35 days is suitable for most tissues and chemicals, while shorter sampling times might be appropriate for highly proliferative tissues. For phage‐based assays, 5 to 10 animals per group should be analyzed, assuming a spontaneous mutant frequency (MF) of ∼3 × 10−5 mutants/locus and 125,000–300,000 plaque or colony forming units (PFU or CFU) per tissue. Data should be generated for two dose groups but three should be treated, at the maximum tolerated dose (MTD), two‐thirds the MTD, and one‐third the MTD. Concurrent positive control animals are only necessary during validation, but positive control DNA must be included in each plating. Tissues should be processed and analyzed in a block design and the total number of PFUs or CFUs and the MF for each tissue and animal reported. Sequencing data would not normally be required but might provide useful additional information in specific circumstances. Statistical tests used should consider the animal as the experimental unit. Nonparametric statistical tests are recommended. A positive result is a statistically significant dose‐response and/or statistically significant increase in any dose group compared to concurrent negative controls using an appropriate statistical model. A negative result is statistically nonsignificant with all mean MF within two standard deviations of the control. Environ. Mol. Mutagen. 35:253–259, 2000Keywords
This publication has 43 references indexed in Scilit:
- Treatment oflacZ plasmid-based transgenic mice with benzo[a]pyrene: Measurement of DNA adduct levels, mutant frequencies, and mutant spectraEnvironmental and Molecular Mutagenesis, 1999
- Comparison of in vivo mutagenesis in the endogenous Hprt gene and the lacI transgene of Big Blue® rats treated with 7,12-dimethylbenz[a]anthraceneMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1998
- Sources of variability in data from a positive selection lacZ transgenic mouse mutation assay: An interlaboratory studyMutation Research - Genetic Toxicology and Environmental Mutagenesis, 1997
- On the origin of spontaneous somatic mutations and sectored plaques detected in transgenic miceMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997
- Sources of variability in mutant frequency determinations in different organs oflacZ plasmid-based transgenic mice: Experimental features and statistical analysisEnvironmental and Molecular Mutagenesis, 1997
- Bacteriophage Lambda and Plasmid lacZ Transgenic Mice for Studying Mutations in VivoPublished by Springer Nature ,1996
- Plasmid-based transgenic mouse model for studying in vivomutationsNature, 1995
- Spontaneous and X-ray-induced deletion mutations in a LacZ plasmid-based transgenic mouse modelMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1995
- Induction of 6‐thioguanine‐resistant lymphocytes in fischer 344 rats following in vivo exposure to n‐ethyl‐n‐nitrosourea and cyclophosphamideEnvironmental and Molecular Mutagenesis, 1991
- A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytesMutation Research/Environmental Mutagenesis and Related Subjects, 1985